Medtronic (BSP:MDTC34) Other Stockholders Equity: R$0 Mil (As of Apr. 2026)


BSP:MDTC34 Medtronic PLC BSP:MDTC34
72 GF Score
Price R$212.73
GF Value R$247.27
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Other Stockholders Equity?

Medtronic BSP:MDTC34 +1.02% 72 Other Stockholders Equity is R$0 Mil as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 72/100 and a GF Value™ of R$247.27 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's Other Stockholders Equity for the quarter that ended in Apr. 2026 was R$0 Mil.

Medtronic's quarterly Other Stockholders Equity increased from Oct. 2025 (R$0 Mil) to Jan. 2026 (R$0 Mil) and increased from Jan. 2026 (R$0 Mil) to Apr. 2026 (R$0 Mil).

Medtronic's annual Other Stockholders Equity declined from Apr. 2024 (R$-0 Mil) to Apr. 2025 (R$-6 Mil) but then increased from Apr. 2025 (R$-6 Mil) to Apr. 2026 (R$0 Mil).

Medtronic Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Medtronic's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Other Stockholders Equity Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -5.79 0.00

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.79 0.00 0.00 0.00 0.00
BSP:MDTC34
72GF Score
Medtronic PLC BSP:MDTC34
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of R$0 Mil mean?
Medtronic (BSP:MDTC34) has a Other Stockholders Equity of R$0 Mil as of Apr. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Medtronic and its competitors.
Is Medtronic's Other Stockholders Equity too high?
Medtronic's current Other Stockholders Equity is R$0 Mil. Overall, Medtronic has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Other Stockholders Equity compare to SYK and BSX?
Medtronic's Other Stockholders Equity of R$0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Medtronic and its competitors. Medtronic's current Other Stockholders Equity is R$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$247.27, compared to a current price of R$212.73 — trading 14% below its estimated fair value. The current Other Stockholders Equity is R$0 Mil. Medtronic's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Other Stockholders Equity is R$0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$212.73 is trading 14% below its estimated GF Value™ of R$247.27. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Other Stockholders Equity: R$0 Mil
  • GF Value™: R$247.27 vs. price of R$212.73 (14% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
72GF Score

Get the complete analysis for BSP:MDTC34

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$212.73
Price
R$247.27
GF Value